Biomarkers such as total IgE, autologous serum test, and cytokines such as IL-4, IL-13 and IL-17, may serve beyond the diagnosis of skin diseases such as CSU and AD, offering insights into therapeutic monitoring. This evidence concerns the gene IL13 and Alzheimer disease.